NASDAQ:SSKNSTRATA Skin Sciences Stock Price, Forecast & News

STRATA Skin Sciences' stock was trading at $1.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SSKN stock has decreased by 9.9% and is now trading at $1.28. View which stocks have been most impacted by Coronavirus.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STRATA Skin Sciences in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for STRATA Skin Sciences.

STRATA Skin Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, August 11th 2020. View our earnings forecast for STRATA Skin Sciences.

STRATA Skin Sciences Inc (NASDAQ:SSKN) issued its earnings results on Tuesday, May, 12th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The medical device company had revenue of $6.73 million for the quarter, compared to the consensus estimate of $6.69 million. STRATA Skin Sciences had a negative return on equity of 12.09% and a negative net margin of 11.27%. View STRATA Skin Sciences' earnings history.

Shares of STRATA Skin Sciences reverse split on the morning of Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.

STRATA Skin Sciences updated its first quarter 2020 Pre-Market earnings guidance on Monday, April, 20th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $6.7-6.9 million, compared to the consensus revenue estimate of $6.2 million.

3 equities research analysts have issued 12-month price objectives for STRATA Skin Sciences' shares. Their forecasts range from $5.00 to $6.00. On average, they expect STRATA Skin Sciences' share price to reach $5.42 in the next year. This suggests a possible upside of 323.2% from the stock's current price. View analysts' price targets for STRATA Skin Sciences.

News stories about SSKN stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. STRATA Skin Sciences earned a news sentiment score of 1.5 on InfoTrie's scale. They also gave news articles about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutSTRATA Skin Sciences.

Some companies that are related to STRATA Skin Sciences include Westaim (WEDXF), TELA Bio (TELA), Soliton (SOLY), Apyx Medical (APYX), BeyondAirInc . (XAIR), RenovaCare (RCAR), Spectral Medical (EDTXF), PAVmed (PAVM), Venus Concept (VERO), BRAINSWAY LTD/S (BWAY), T2 Biosystems (TTOO), SANUWAVE Health (SNWV), AIT Therapeutics (AITB), Pro-Dex (PDEX) and Nephros (NEPH). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other STRATA Skin Sciences investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Amarin (AMRN), Plug Power (PLUG), Tonix Pharmaceuticals (TNXP), Kopin (KOPN), Onconova Therapeutics (ONTX), Agile Therapeutics (AGRX), Biocept (BIOC) and Capstone Turbine (CPST).

STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."

STRATA Skin Sciences' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (0.33%). Company insiders that own STRATA Skin Sciences stock include Luann Via, Matthew C Hill and Samuel E Navarro. View institutional ownership trends for STRATA Skin Sciences.

SSKN stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc.. Company insiders that have bought STRATA Skin Sciences stock in the last two years include Luann Via, Matthew C Hill, and Samuel E Navarro. View insider buying and selling activity for STRATA Skin Sciences.

Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SSKN stock can currently be purchased for approximately $1.28.

STRATA Skin Sciences has a market capitalization of $43.15 million and generates $31.59 million in revenue each year. The medical device company earns $-3,790,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis. STRATA Skin Sciences employs 98 workers across the globe.

The official website for STRATA Skin Sciences is www.strataskinsciences.com.

STRATA Skin Sciences' mailing address is 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA, 19044. The medical device company can be reached via phone at 215-619-3200 or via email at [email protected]